Corpus Intelligence IC Memo — HAMPTON REGIONAL MEDICAL CENTER 2026-04-26 15:55 UTC
IC Memo — HAMPTON REGIONAL MEDICAL CENTER
Investment Committee Memorandum | SC | 32 beds | Grade C | EBITDA uplift $1.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HAMPTON REGIONAL MEDICAL CENTER

CCN 420072 | HAMPTON, SC | 32 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

HAMPTON REGIONAL MEDICAL CENTER is a 32-bed under-performing / distressed in HAMPTON, SC with $24.0M in net patient revenue and a -21.2% operating margin. The hospital serves a payer mix of 27.8% Medicare, 3.0% Medicaid, and 69.3% commercial.

Thesis: Turnaround. Our ML models identify $1.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -21.2% to -13.9% (+736bps).

Net Revenue HCRIS$24.0M
Current EBITDA COMPUTED$-5.1M
Operating Margin COMPUTED-21.2%
Occupancy HCRIS22.9%
Revenue / Bed COMPUTED$751K
Net-to-Gross HCRIS33.1%
Distress Probability ML54.9%

2. Market Context & Competitive Position

85
SC Hospitals
1.3%
State Median Margin
36
Comparable Hospitals

SC has 85 Medicare-certified hospitals with a median operating margin of 1.3%. The target's margin of -21.2% places it below the state median. Among 36 size-comparable peers (16-64 beds), the median margin is 1.5%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (16-64), prioritizing same-state peers. 36 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HAMPTON REGIONAL MEDICAL CENTE (Target)SC32$24.0M-21.2%
PH PATEWOOD HOSPITALSC64$229.8M38.0%
PELHAM MEDICAL CENTERSC48$137.2M17.1%
PH HILLCREST HOSPITALSC43$123.6M30.8%
ROPER ST. FRANCIS HOSPITAL-BERSC46$119.0M13.0%
PH BAPTIST EASLEY HOSPITALSC64$118.3M19.6%
PH LAURENS COUNTY HOSPITALSC41$109.4M13.5%
COASTAL CAROLINA MEDICAL CENTESC41$94.8M24.9%
CHEROKEE MEDICAL CENTERSC25$61.2M8.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$504K+210bp18mo
Cost to Collect4.5%2.5%$480K+200bp12mo
Denial Rate Reduction12.0%6.5%$476K+198bp12mo
A/R Days Reduction5200.0%3800.0%$292K+122bp9mo
Clean Claim Rate88.0%96.0%$15K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$504K
Cost to Collect
$480K
Denial Rate Reduction
$476K
A/R Days Reduction
$292K
Clean Claim Rate
$15K
Total EBITDA Uplift$1.8M
Current EBITDA$-5.1M
+ RCM Uplift+$1.8M
Pro Forma EBITDA$-3.3M
Current Margin-21.2%
Pro Forma Margin-13.9%
WC Released (1x)$921K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-7.8M$-15.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-7.8M$-20.1M0.00x-100.0%
Bull Case9.0x11.0x$-7.1M$-16.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-7.1M$-20.4M0.00x-100.0%
Bear Case11.0x10.0x$-8.6M$-22.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-8.6M$-27.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 22.9%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 54.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 36 hospitals with 16-64 beds
  • Same-state prioritization (n=37)
  • Comp margins: P25=-14.1% / P50=1.5% / P75=15.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.